1. Pharmaceutical compositions of saturated lipid polymer matrix of curcumin (Indian Patent No. 386528)
2. Pharmaceutical compositions of saturated lipid polymer matrix of curcumin (Indian Patent No. 386528)
3. Process for preparation of free flowing, non-sticky, porous and highly loaded spherules (Indian Patent No. 211495)
4. Process for preparation of self micro/nano emulsifying systems and compositions thereof (Indian Patent No. 208589)
5. Lipidic nanoparticulate based dosage forms of antiparasitics and antiinfectives (Indian patent No. 248977)
6. Lipidic nanoparticles based composition and method of formulation and use thereof (3329/MUM/2010)
7. Pharmaceutical composition of curcumin (Indian Patent No. 283059)
8. Highly porous tablet (Indian Patent No. 341894)
9. Novel Lipid Based Carrier (Indian Patent no. 364963)

1. Point of care diagnostic device for early detection of vitamin-B12 deficiency in non-serological sample (201921017921)
2. Glycerol monolaurate based microemulsion and drug delivery system (201821019697)   
3. Novel dendrimer and application thereof (201621034246)
4. Stable atovaquone nanoparticles with increased bioavailability and pharmaceutical composition of the same (201621020162)
5. Novel targeted lipid bioconjugates and delivery system thereof (2822/MUM/2015)
6. Nanodrug delivery based on combination therapy for treating parasite infections (3567/MUM/2013)
7. Point-of-care diagnostic test for rapid detection of brucellosis (3183/MUM/2013)
8. Non-invasive vaccine delivery system for immunization against brucellosis using green technology (2920/MUM/2013)
9. Pharmaceutical composition for combined immunization and therapy against macrophage host related infections (2266/MUM/2012)
10. Pharmaceutical composition for transdermal application (1218/MUM/2012)
11. Pharmaceutical composition for bioenhancement of active agents (1108/MUM/2012)
12. Microparticles Preparation and Process Thereof: Process Optimization and Equipment Design (652/MUM/2010)
13. Stable Solutions of Sparingly Soluble Actives (WO/2009/066146)
14. Polymeric Nanoparticles of Curcumin for Improved Delivery (103/MUM/2008)
15. Stable solutions of poorly soluble actives (2281/MUM/2007)
16. Nanoparticles for wound healing (256/MUM/2007)
17. Biosurfactants from natural source (1945/MUM/2006)
18. Solid solutions of Pharmaceutical actives (1872/MUM/2006)

1. Pharmaceutical composition of curcumin US 20130225689 A1
2. Pharmaceutical composition of taxoids 20130310447 A1, US 9345683 B2 

1. Stable Solutions Of Sparingly Soluble Actives (US 2011/0020440 A1)
2. Compositions and coatings for implantable medical Devices (US 2007212393A1)
3. Compositions comprising porous articles and uses in implantable medical devices (US2007212388A1)
4. Coatings for implantable medical devices (US2007212387A1)
5. Coatings for implantable medical devices (US2007212386A1)

1. Pharmaceutical composition of curcumin EP 2616053A2, EP 2616053A4
2. Pharmaceutical composition of taxoids EP 2637655 A1
3. mTOR inhibitor eluting medical device EP3027236 A1

1. Compositions and coatings for implantable medical devices (EP1832289A2)
2. Coatings for implantable medical devices (EP1832301A2)
3. Compositions comprising porous articles and uses in implantable medical devices (EP1834636A1).

1. Pharmaceutical composition of taxoids (WO/2012/063182)

1. Stable solutions of sparingly soluble actives (WO/2009/066146)

1. Registered Trademark "DO-SOL" for pulmonary delivery of therapeutics (No. 2700724, Dated 18 March 2014)
2. Registered Trademark "NANOTARG" for targeting diagnostic nanoparticles (No. 1529980, Dated 12 February 2007)
3. Registered Trademark SMETS®- for Self Micro-Emulsifying Tablets, a new drug delivery system. (No. 1250909, Dated 21 November 2003)

1. Industrial design for Inhaler device - No. 261054 (Certificate No: 37238), Dated 18 March 2014

1. S.P. Bhavsar, M.S. Kumar, V.B. Patravale, 2022, Marine Adhesive Proteins for Novel Applications, Marine Biochemistry, CRC Press, Pages17.
2. A. Pandya, P. Upadhaya, S. Lohakare, T. Srivastava, S. Mhatre, S. Pulakkat, V. Patravale, Chapter 6 - Nanobiomaterials for regenerative medicine, Editor(s): Huinan H. Liu, Tolou Shokuhfar, Sougata Ghosh, In Elsevier Series on Advanced Topics in Biomaterials, Nanotechnology in Medicine and Biology, Elsevier, 2022, 141-187.
3. S. Wairkar, V. Patravale Targeted Delivery of Biopharmaceuticals for Neurodegenerative Disorders, In Book Biotechnology in the Modern Medicinal System 2021 Apple Academic Press, 46
4. P. Kakade, S. Wairkar, S. Lohakare, P. Shah, V. Patravale. Probiotics for Atopic Dermatitis: An Update. In Probiotic Research in Therapeutics, Springer, Singapore.2022, 197-244. 
5. A. Pandya, S. Pulakkat, S. Jadhav, V. Patravale. Probiotics as Edible Vaccines. In Probiotic Research in Therapeutics, Springer, Singapore. 2022, 269-293. 
6. A. Agrawal, K. Pawar, V. Ghegade, A. Kapse, V. Patravale. Nanobiomaterials for medical devices and implants. In Nanotechnology in Medicine and Biology, Elsevier, 2022, 235-272.
7. A. Manjappa, P. Kumbhar, J. Disouza, S. Pattekari, V. Patravale. Formulation Strategies for Improved Ophthalmic Delivery of Hydrophilic Drugs. Micro- and Nanotechnologies-Based Product Development. Chapter 8, CRC Press, 1st Ed. 20, 115-138, 2021
8. S. Pulakkat, V. Patravale, Immunogene Therapy in Cancer, In Book Biotechnology in the Modern Medicinal System, ImprintApple Academic Press, Pages30
9. P. Upadhaya, S. Pulakkat, V. Patravale, Chapter 15 - Diagnostic and theranostic intranasal nanointerventions for brain diseases, Editor(s): Chandrakantsing V. Pardeshi, Eliana B. Souto, Direct Nose-to-Brain Drug Delivery, Academic Press, 2021, 287-303.
10. R. Osmani, E. Singh, R. Bhosale, R. Vaghela, V. Patravale, Chapter 7 - Nanotherapeutic platforms for osteoarticular tuberculosis, Editor(s): Mariappan Rajan, A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy, Academic Press, 2021,175-199.
11. P. Desai, V. Patravale. In Vitro–In Vivo Correlation for Pharmaceutical Nano‐ and Microsystems. Characterization of Pharmaceutical Nano and Microsystems. John Wiley & Sons, Ltd. 137-170, 2021
12. P. Upadhaya S. Talkar, V. Ghodake, N. Kadwadkar, A. Pandya, S. Pulakkat, V. Patravale. Targeted Lipid-Based Nanoparticles for Nucleic Acid Delivery in Cancer Therapy, Micro- and Nanotechnologies-Based Product Development. Chapter 7, CRC Press, 1st Ed. 95-114, 2021
13. P. Upadhaya, P. Kharkar, A. Patil, S. Pawar, J. Disouza, V. Patravale. Probiotics and Cancer: Boosting the Immune System. Probiotic Research in Therapeutics. Springer, Singapore. 47-67, 2021
14. A. Manjappa, P. Kumbhar, J. Disouza, S. Pattekari, V. Patravale. Formulation Strategies for Improved Ophthalmic Delivery of Hydrophilic Drugs. Micro- and Nanotechnologies-Based Product Development. Chapter 8, CRC Press, 1st Ed. 20, 115-138, 2021
15. A.Mirani, T. Shah, V. Patravale. Marine Source‐derived Anti‐HIV Therapeutics. Encyclopedia of Marine Biotechnology, Wiley-Blackwell Publisher. Chapter 121, 2725-2753, 2020
16. R. Prabhu, V. Patravale. Marine‐derived Pharmaceuticals for Oncotherapy: Clinical Trial and FDA‐approved Compounds. Encyclopedia of Marine Biotechnology. Wiley-Blackwell Publisher. Chapter 117, 2607-2618, 2020
17. M. Kumar, V. Patravale. Marine‐derived Potential Anti‐inflammatory Agents, Encyclopedia of Marine Biotechnology. Wiley-Blackwell Publisher. Chapter 116, 2585-2605, 2020
18. S. Pund, A.Joshi, V. Patravale. Modulating Functionality of Beverages Through Nanostructured Interventions. Nanoengineering in the Beverage Industry, Volume 20: the Science of Beverages, Pages 197-227, 2020 
19. S. Dhoble, S.Dhage, Sreeranjini P, V. Patravale. Opportunities and Challenges in Targeted Carrier-Based Intracellular Drug Delivery: Increased Efficacy and Reduced Toxicity, Novel Drug Delivery Technologies, 403-431, 2019
20. V. Patravale, P. Upadhaya, R. Jain. Preparation and Characterization of Micelles. Methods in molecular biology (MIMB) “Protocols in Pharmaceutical Nanotechnology” Chapter 2, 2019
21. M. Joshi, R. Prabhu, V. Patravale. Fabrication of nanostructure lipid carriers (NLC) based gels from microemulsion template for delivery through skin. Methods in molecular biology (MIMB) “Protocols in Pharmaceutical Nanotechnology” Chapter 19, 2019
22. V. Patravale A. Mirani. Preparation and Characterization of Solid lipid nanoparticles based gel for Topical Delivery. Methods in molecular biology (MIMB) “Protocols in Pharmaceutical Nanotechnology” Chapter 20, 2019
23. V. Ghodake, S. Naik, K. Bhukhanwala, K. Kande, N. Bhor, V. Patravale. Nanoengineered Systems for Biopesticides. Handbook of Nanomaterials for Industrial Applications, Chapter 14, 243-259, 2018
24. R. Pawar, P. Upadhaya, V. Patravale. Quantum Dots: Novel Realm in Biomedical and Pharmaceutical Industry. Handbook of Nanomaterials for Industrial Applications. Chapter 34, 621-637, 2018
25. V. Patravale, P. Desai, S. Mapara. Lipid Nanocarriers for Advanced Therapeutic Applications. IGI Global publisher. DOI: 10.4018/978-1-5225-4781-5.ch005. 2018
26. V. Patravale, A. Joshi. An overview of the therapeutic aspect of living drugs probiotics. IGI Global publisher. 1-34, 2018
27. J. Disouza, K. Patil, P. Kakade, V. Patravale. Dietary Fibers and Nutraceuticals in Prevention of Hypertension. IGI Global publisher. 192-232, 2018
28. V. Patravale, S. Naik, S. Dhage. Role of Diet, Functional Foods, and Nutraceuticals in Brain Disorders. IGI Global publisher. 256-287, 2018
29. V. Patravale, N. Kadwadkar, S. Patki, J. Disouza. Nutraceutical and Functional Foods in Treatment of Anemia. IGI Global publisher. 308-339, 2018
30. S. Talkar, S. Dhoble, A. Majumdar, V. Patravale. Transmucosal Nanoparticles: Toxicological Overview, Kluwer publisher, Advances in Experimental Medicine and Biology in Cellular and Molecular Toxicology of Nanoparticles. 1048:37-57, 2018. DOI: 10.1007/978-3-319-72041-8_3.
31. S. Dhoble, V. Ghodake, M. Chogale, V. Patravale. Nanoformulations for the Therapy of Pulmonary Infections. Nanostructures for antimicrobial therapy, Elsevier publisher, Chapter 20, 457-477, 2017
32. P. Kharkar, S. Talkar, N. Kadwadkar, V. Patravale. Nanosystems for oral delivery of immunomodulators. Nanostructures for oral medicine, Elsevier publisher, Chapter 11, 295-328, 2017
33. S. Karandikar, A. Mirani, V. Waybhase, V. Patravale, S. Patankar. Nanovaccines for oral delivery- formulation strategies and challenges. Nanostructures for oral medicine, Elsevier publisher, Chapter 10, 263-289, 2017
34. R. Prabhu, K. Bhise and V. Patravale. Marine Enzymes in Cancer: A New Paradigm (Editors: Se-Kwon Kim and Fidel Toldrá)  in Advances in Food and Nutrition Research (Marine Enzymes Biotechnology: Production and Industrial Applications, Part III- Application of Marine Enzymes), Elsevier publisher, 2016 (doi: 10.1016/bs.afnr.2016.10.001)
35. S. Pund, A. Joshi, V. Patravale, Improving bioavailability of nutraceuticals by nanoemulsification, In: Grumezescu, A.M.(Eds) Nutraceuticals, Nanotechnology in the agri-food industry. Elsevier (Academic Press), Cambridge, UK, vol. 4, 481-534, 2016
36. P. Prabhu, F. Shiekh, and V. Patravale, Nanotherapeutics: Future Medicine for Infectious Diseases, Accepted proof for publication in e-book: Frontiers in Drug Design & Discovery, 2016, Volume 7
37. P. Prabhu*, S. Vyas*, A. Date*, V. Torchilin, J. Disouza, and V. Patravale, Nanotheranostics, Accepted proof for publication in Encyclopedia of Nanoscience and Nanotechnology. 2016. *Equal authorship. 
38. V. Patravale, S. Jain, S. Sharma. Phytopharmaceuticals for antimalarial therapy (Ed. Priyanka Ingle Jadhav, Majoy Jadhav, Nilima Kshirsagar) in Emerging Trends in Phytopharmaceuticals. CBS Publisher, Chapter 10, 2014
39. V. Patravale, P. Prabhu. Lipid based drug delivery systems (Ed. N. Udupa and Srinivas Mutalik) In Recent Trends in Novel Drug Delivery, Prism Books Pvt. Ltd, 80-167, 2014
40. V. Patravale, P. Desai. Topical Nanointerventions for Therapeutic and Cosmeceutical Applications(Ed. Prof. Abraham J. Domb, and Dr. Wahid Khan) In Focal Controlled Drug Delivery, Springer publishers Chapter 24, 535-560, 2014
41. S. Vyas, V. Patravale. Molecular nanotechnology: Rapid detection of microbial pathogens in food (Ed. V. Ravishankar Rai and A Jamuna Bai) In Microbial Food Safety and Preservation techniques, Chapter 10, Taylor and Francis Group, CRC Publishers, 2014
42. V. Patravale, S. Vyas. Chitosans as delivery vectors in biomedical applications (Ed. Se-Kwon Kim) In Chitin and chitosan derivatives: Advances in drug discovery and developments, Chapter 21, Taylor and Francis Group, CRC Publishers, 2013.
43. C. Fernandes, P. Prabhu, D. Gugulothu, V. Patravale. Lipid Nanocarriers for Topical Anti-cancer Therapy: An Update (Ed. Eliana Souto) In Lipid Nanocarriers in Cancer Diagnosis and Therapy, Chapter 15, iSmithers Rapra Publishing, 2011
44. V. Patravale, M. Joshi. "Nanocarriers for Imaging applications in Colloids in Drug Delivery" (Ed. Monzer Fanun), In Colloids in Drug Delivery, Chapter 25, Taylor and Francis Group, 2010
45. V. Patravale, A. Date. Microemulsions in Pharmaceutical formulations (Ed. Cosima Stubenrauch) In Microemulsions, Chapter 9, Blackwell Publishing, 2007

INTERNATIONAL 

1. Y. Mirchandani, V. Patravale, S. Brijesh. Hyaluronic acid-coated solid lipid nanoparticles enhance antirheumatic activity and reduce toxicity of methotrexate. Nanomedicine (Lond). 2022 Sep 30. PMID: 36178114.
2. P. Khare, M. Chogale, P. Kakade, V. Patravale. Gellan gum–based in situ gelling ophthalmic nanosuspension of Posaconazole. Drug delivery and translational research, 2022, 1-16.
3. V. Borhade, S. Sharma, S. Pathak and V. Patravale, Corrigendum to article "Clotrimazole nanoemulsion for malaria chemotherapy. Part II: Stability assessment, in vivo pharmacodynamic evaluations and toxicological studies" [Int. J. Pharm. 431(1-2) (2012) 149-160]; (2022)
4. P. Kakade, Z. Pathan, S. Gite, A. Mirani, V. Patravale. Nanoparticle Engineering of Aprepitant Using Nano-by-Design (NbD) Approach. AAPS PharmSciTech, 2022, 23(6), 204.
5. S. Dhoble, V. Patravale. SIRT 1 Activator Loaded Inhaled Antiangiogenic Liposomal Formulation Development for Pulmonary Hypertension. AAPS PharmSciTech. 2022 Jun 8;23(5):158.
6. S. Pukale, A. Pandya, V. Patravale, Synthesis, characterization and topical application of novel bifunctional peptide metallodendrimer, Journal of Drug Delivery Science and Technology, 2021, 66, 102925.
7. S. Mhatre, N. Gurav, M. Shah, V. Patravale. Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant. Computers in Biology and Medicine, 2021, 135, 104560.
8. Y. Sutar, S. Fulton, S. Paul, S. Altamirano, S. Mhatre, H. Saeed, P. Patel, S. Mallick, R. Bhat, V. Patravale, H. Chauhan, K. Nielsen, A. Date. Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and in Vitro Activity against Cryptococcus neoformans. ACS infectious diseases, 2021, 7(9), 2637–2649.
9. M. Chogale, S. Gaikwad, S. Kulkarni V. Patravale. Quality-by-design Enabled Chitosan Nanoparticles for Antitubercular Therapy: Formulation, Statistical Optimization, and In Vitro Characterization, Current Drug Therapy 16(1), 2021, 64 – 82.
10. M. Chogale, S. Dhoble, V. Patravale A triple combination 'nano' dry powder inhaler for tuberculosis: in vitro and in vivo pulmonary characterization. Drug Deliv. Transl. Res., 11, 1520–1531, (2021)
11. S. Mhatre, S. Naik, V. Patravale. Exploring green and industrially scalable microfluidizer™ technology for development of barium sulphate nanosuspension for enhanced contrasting, J Drug Deliv Sci Technol, 64, 102567, (2021)
12. P. Patel, A. Pol, D. Kalaria, A. Date, Y. Kalia, V. Patravale. Microemulsion-based gel for the transdermal delivery of rasagiline mesylate: In vitro and in vivo assessment for Parkinson’s therapy, Eur. J. Pharm. Biopharm. 165, 66-74, (2021)
13. S. Mhatre, N. Gurav, M. Shah, V. Patravale. Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant. Comput. Biol. Med., 135, 104560 (2021)
14. M. Sane, V. Dighe, R. Patil, P. Hassan, S. Gawali, V. Patravale. Bivalirudin and sirolimus co-eluting coronary stent: Potential strategy for the prevention of stent thrombosis and restenosis Int. J. Pharm., 120403, 600 (2021)
15. S. Dhoble, V. Ghodake, V. Peshattiwar, V. Patravale. Site-specific delivery of inhalable antiangiogenic liposomal dry powder inhaler technology ameliorates experimental pulmonary hypertension, J Drug Deliv Sci Technol, 62, 102396 (2021)
16. S Gite, P Kakade, V Patravale, Surface Engineering of Fenofibrate Nanocrystals Using Nano-by-Design Multivariate Integration: A Biopharmaceutical and Pharmacokinetic Perspective, Current Drug Delivery, doi: 10.2174/1567201818666210224100700 (2021)
17. S Mhatre, S Naik, V Patravale, A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2, Computers in biology and medicine, 129:104137 (2021)
18. V. Ghodake, J. Vishwakarma, SL. Vavilala, V. Patravale. Cefoperazone sodium liposomal formulation to mitigate P. aeruginosa biofilm in Cystic fibrosis infection: A QbD approach. Int J Pharm. (2020)
19. R. Pawar, V. Patravale. A Step towards Treating Dengue Viral Infection: An In Silico Approach to Identify Potential Antidengue Phytoconstituents. ChemistrySelect. 5 (44): 13837-13854 (2020). 
20. S. Vyas, S. Dhoble, V. Ghodake, V. Patravale. Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology. International Journal of Pharmaceutics: X. 2, 100053 (2020)
21. S. Vyas, M. Khambete, R. Gudhka, S. Panchamia, M. Degani & V. Patravale. In silico modeling of functionalized poly(methylvinyl ether/maleic acid) for controlled drug release in the ocular milieu. Drug Deliv Trans Res. (2020)
22. S. Vyas, M. Khambete, R. Gudhka, S. Panchamia, M. Degani & V. Patravale. Network topology of LMWG cross-linked xyloglucan hydrogels for embedding hydrophobic nanodroplets: mechanistic insight and molecular dynamics. Drug Deliv Trans Res. (2020)
23. M. Chogale, S. Gite, V. Patravale. Comparison of media milling and microfluidization methods for engineering of nanocrystals: a case study. Drug Development and Industrial Pharmacy, DOI: 10.1080/03639045.2020.1821046 (2020)
24. P. Kakade, S. Gite, V. Patravale. Development of Atovaquone Nanosuspension: Quality by Design Approach. Current drug delivery. 17(2): 112-125(2020)
25. P. Kharkar, S. Talkar, V. Patravale. An industrially viable technique for fabrication of docetaxel NLCs for oncotherapy. International Journal of Pharmaceutics. 577:  119082 (2020)
26. R. Bhuptani, V. Patravale. Starch microsponges for enhanced retention and efficacy of topical sunscreen. Materials Science and Engineering: C. 104: 109882 (2019)
27. A. Mirani, H. Kundaikar, S. Velhal, V. Patel, A. Bandivdekar, M. Degani, V. Patravale. Evaluation of phytopolyphenols for their gp120-CD4 binding inhibitory properties by in silico molecular modelling & in vitro cell line studies. Curr HIV Res. 7(2):102-113, 2019
28. R. Bhuptani, V. Patravale. Starch microsponges for enhanced retention and efficacy of topical sunscreen. Materials Science and Engineering: C.2019
29. S. Dhoble, V. Patravale. Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach.Drug Deliv. Transl. Res. 9(5):980-996, 2019
30. A. Mirani, H. Kundaikar, S. Velhal, V. Patel, A. Bandivdekar, M. Degani, V. Patravale. Tetrahydrocurcumin-loaded vaginal nanomicrobicidefor prophylaxis of HIV/AIDS: in silico study, formulation development, and in vitro evaluation. Drug Deliv Transl Res. 9(4):828-847, 2019
31. A. Mirani, S. Gite, V. Patravale. Optimization and Validation of Reversed Phase High Performance Chromatography Method for Rapid Estimation of Theaflavin. Anal. Chem. Lett. 8 (5): 587-600, 2018 
32. D Kalaria, M Singhal, V Patravale, V Merino, Y Kalia. Simultaneous Controlled Iontophoretic Delivery of Pramipexole and Rasagiline in Vitro and in Vivo : Transdermal Polypharmacy to Treat Parkinson’s Disease. European Journal of Pharmaceutics and Biopharmaceutics 127: 204–212, 2018
33. P. Desai, V. Patravale. Curcumin Cocrystal Micelles—Multifunctional Nanocomposites for Management of Neurodegenerative Ailments. Journal of Pharmaceutical Sciences. 107(4): 1143–1156, 2018
34. P Kharkar, S Talkar, V Patravale. A Rapid and Sensitive Bio Analytical RP-HPLC Method for Detection of Docetaxel: Development and Validation. Indian Journal of Pharmaceutical Education and Research 51(4s): s729–s734, 2017
35. A. Darade, S. Pathak, S. Sharma, V. Patravale. Atovaquone oral bioavailability enhancement using electrospraying technology. European Journal of Pharmaceutical Sciences. 111: 195-204, 2018
36. P. Prabhu, S. Suryavanshi, S. Pathak, A. Patra, S. Sharma, V. Patravale. Nanostructured lipid carriers of artemether–lumefantrine combination for intravenous therapy of cerebral malaria. International Journal of Pharmaceutics. 513(1-2): 504-517, 2016
37.  R. Bhuptani, V.  Patravale. Porous microscaffolds for 3D culture of dental pulp mesenchymal stem cells. International Journal of Pharmaceutics 30;515 (1-2): 555-564, 2016
38. P. Prabhu, S. Suryavanshi, S. Pathak, S. Sharma, V. Patravale. Artemether–lumefantrine nanostructured lipid carriers for oral malaria therapy: Enhanced efficacy at reduced dose and dosing frequency. International Journal of Pharmaceutics. 511(1): 473–487, 2016
39. L. Kate, V. Gokarna, V. Borhade, P. Prabhu, V. Deshpande, S. Pathak,S. Sharma, V. Patravale, Bioavailability enhancement of atovaquone using hot melt extrusion technology. European Journal of Pharmaceutical Sciences. 2016, doi: 10.1016/j.ejps.2016.03.005. [Epub ahead of print]
40. Chougle J, Bankar S, Chavan P, Patravale V & Singhal R, Supercritical carbon dioxide extraction of astaxanthin from Paracoccus NBRC 101723: Mathematical modelling study. Separation Science and Technology. 10.1080/01496395.2016.1178288: 2016
41. P. Prabhu, V. Patravale, Dissolution enhancement of atorvastatin calcium by co-grinding technique. Drug Deliv Transl Res. 2015 Dec 28. [Epub ahead of print]
42. S. Gite, V. Patravale. Validation of RP-HPLC Method and Stress Degradation for the Combination of Metformin HCl, Atorvastatin Calcium and Glimepiride: Application to Nanoparticles. Journal of Chromatographic Science; doi: 10.1093/chromsci/bmv068: 1-9 (2015)
43. M. Chaudhari, P. Desai, P. Patel, V. Patravale. Solid lipid nanoparticles of amphotericin B (AmbiOnp): in vitro and in vivo assessment towards safe and effective oral treatment module. Drug Delivery and Translational Research, 2015, (Ahead of Publication), PMID: 26712123
44. H. Shete, S. Sable, P. Tidke, N. Selkar, Y. Pawar, A. Chakraborty, A. De, G. Venage, V. Patravale. Mono-guanidine heterolipid based SMEDDS: A promising tool for cytosolic delivery of antineoplastics. Biomaterials; 57 :116-132 (2015)
45. S. Vyas, S. Jadhav, S. Majee, J. Shastri, V. Patravale. Development of immunochromatographic strip test using fluorescent, micellar silica nanosensors for rapid detection of B. abortus antibodies in milk samples.  Biosensors and Bioelectronics; 70: 254-260 (2015)
46. S. Jain*, H. Basu*, P. Prabhu, U. Soni, M. Joshi, D. Mathur, V. Patravale, 2. S. Pathak, S. Sharma. Parasite Impairment by Targeting Plasmodium-Infected RBCs Using Glyceryl-dilaurate Nanostructured Lipid Carriers. Biomaterials; 35(24):6636-45 (2014) (*Equal authorship)
47. D. Kalaria, P. Patel, V. Merino, V. Patravale, Y. Kalia. Controlled iontophoretic delivery of pramipexole: Electrotransport kinetics in vitro and in vivo. European Journal of Pharmaceutics and Biopharmaceutics; 88: 56-63 (2014)
48. P. Patel, A. Pol, S. More, D. Kalaria, Y. Kalia,  V. Patravale. Colloidal Soft Nanocarrier for Transdermal Delivery of Dopamine Agonist: Ex Vivo and In Vivo Evaluation. Journal of Biomedical Nanotechnology; 10: 3291-3303 (2014)  
49. H. Shete, N. Selkar, G. Vanage, V. Patravale. Tamoxifen Nanostructured Lipid Carriers: Enhanced in vivo Antitumor Efficacy with Reduced Adverse Drug Effects. Int. J. Pharm.; 468(1-2):1-14 (2014)
50. D. Gugulothu, V. Patravale, P. Dandekar. pH-Sensitive Nanoparticles of Curcumin-Celecoxib Combination: Evaluating Drug Synergy in Ulcerative Colitis Model, J. Pharm. Sci.; 103(2):687-96 (2014)
51. V. Borhade, S. Pathak, S. Sharma, V. Patravale. Formulation and characterization of atovaquone nanosuspension for improved oral delivery in the treatment of malaria. Nanomedicine. [Epub ahead of print] doi: 10.2217/nnm.13.61 (2013)
52. D. Gugulothu, P. Desai, P. Pandharipande, V. Patravale. Freeze drying: exploring potential in development of orodispersible atblets of sumatriptan succinate; Drug Dev. Ind. Pharm. 2013 [Epub ahead of print].doi: 10.3109/03639045.2013.871551 (2013)
53. D. Gugulothu, P. Desai, V. Patravale; A Versatile Liquid Chromatographic technique for pharmacokinetic estimation of curcumin in human plasma. Journal of Chromatographic Science. 52: 872-879 (2013) 
54. D. Gugulothu, V. Patravale. Stability-indicating HPLC Method for Arteether and application to nanoparticles of arteether. Journal of Chromatographic Science. doi: 10.1093/chromsci/bmt125. 1-6 (2013)
55. S. Patil, V. Patravale. Evaluation of novel lipid based formulation of β -Artemether and Lumefantrine in murine malaria model. Int. J. Pharm.; 455(1-2):229-34 (2013)
56. C. Fernandes , S. Mandawgade , V. Patravale. Solid lipid nanoparticles of etoposide using solvent emulsification diffusion technique for parenteral administration; Int. J.Pharm. Biosci. Technol.; 1(1): 27-33 (2013)
57. S. Subramanian, U. Pandey, D. Gugulothu, V. Patravale, G. Samuel. Modification of PLGA Nanoparticles for Improved Properties as a 99mTc-Labeled Agent in Sentinel Lymph Node Detection; Cancer Biotherapy & Radiopharmaceuticals; 28(8): 598-606 (2013)
58. D. Kalaria, P. Patel, V. Merino, V. Patravale, Y. Kalia. Controlled iontophoretic transport of huperzine a across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models; Molecular Pharmaceutics; 10(11): 4322-4329 (2013)
59. S. Harde, L. Kagliwal, R. Singhal, V. Patravale. Supercritical fluid extraction of forskolin from Coleus forskohlii roots. Journal of food engineering, 117: 443-449 (2013)
60. H. Shete, S. Chatterjee, A. De, V. Patravale. Long chain lipid based Tamoxifen NLC. Part II: Pharmacokinetic, biodistribution and in vitro anticancer efficacy studies. International Journal of Pharmaceutics.  454(1): 584-92 (2013)
61. H. Shete, V. Patravale. Long chain lipid based Tamoxifen NLC. Part I: Preformulation studies, formulation development and physicochemical characterization. International Journal of Pharmaceutics. 454(1): 573-83 (2013)
62. P. Patel, S. Patil, D. Kalaria, Y. Kalia, V. Patravale. Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A. International Journal of Pharmaceutics, 446(1-2): 16-23 (2013)
63. D. Kalaria, P. Patel, V. Patravale, Y. Kalia. Comparison of the Cutaneous Iontophoretic Delivery of Rasagiline and Selegiline across Porcine and Human Skin In Vitro, International Journal of Pharmaceutics, 438(1-2): 202-208 (2012)
64. K. Kumthekar, V. Patravale and J. Nagarkar. Formulation, Rheology, and Hypolepidemic Activity of Vegetable Oil-Based Eggless and Low-Fat Food Emulsions, Journal of Dispersion Science and Technology, 33(7):1006-1011 (2012)
65. V. Parekh, V. Patravale and A. Pandit.  Mango kernel fat: A novel lipid source for the fermentative production of sophorolipid biosurfactant using Starmerella Bombicola NRRL-Y 17069, Annals of biological research, 3(4):1798-1803 (2012)
66. D. Gugulothu, V. Patravale. A New Stability-Indicating HPLC Method for Simultaneous Determination of Curcumin and Celecoxib at Single Wavelength: an Application to Nanoparticulate Formulation, Pharm. Anal. Acta, 3(4): 157 (2012)
67. D. Gugulothu, C. Fernandes, V. Patravale. A Versatile High Performance Liquid Chromatography Method for Simultaneous Determination of Three Curcuminoids in Pharmaceutical Dosage forms, Pharm. Anal. Acta., 3(4): 156 (2012)
68. V. Borhade, S. Sharma, S. Pathak, V. Patravale. Clotrimazole nanoemulsion for malaria chemotherapy. Part I: Preformulation studies, formulation design and physiochemical evaluation, Int. J. Pharm., 431(1-2): 138-148 (2012)
69. V. Borhade, S. Sharma, S. Pathak, V. Patravale. Clotrimazole nanoemulsion for malaria chemotherapy. Part II: Stability assessment, in vivo pharmacodynamic evaluations and toxicological studies, Int. J. Pharm., 431(1-2): 149-160 (2012)
70. L. Kagliwal, A. Pol, S. Patil, R. Singhal, V. Patravale, Antioxidant-Rich Extract from Dehydrated Seabuckthorn Berries by Supercritical Carbon Dioxide Extraction, Food Bioprocess Technol., 5 (7): 2768-2776 (2012)
71. L. Kagliwal, S. Patil, A. Pol, R. Singhal, V. Patravale. Separation of bioactives from seabuckthorn seeds by supercritical carbon dioxide extraction methodology through solubility parameter approach, Separation and Purification Technology 80: 533–540 (2011)
72. P. Patel, V. Patravale. AmbiOnp: Solid Lipid Nanoparticles of Amphotericin B for Oral Administration, Journal of Biomedical Nanotechnology, 7(5): 632–639 (2011)
73. R. Patale, V. Patravale. O, N- Carboxymethyl chitosan-Zinc Complex: A novel chitosan complex with enhanced antimicrobial activity; Carbohydrate Polymers, 85(1): 105-110 (2011)
74. D. Gugulothu, S. Pathak, S. Suryavanshi, S. Sharma, V. Patravale. Self-Microemulsifiyng Suppository Formulation of β-Artemether, AAPS PharmSciTech; 11(3): 1179-84 (2010)
75. S. Subramanian, P. Dandekar, R. Jain, U. Pandey, G. Samuel, P. Hassan, V. Patravale, M. Venkatesh. Technetium-99m–Labeled Poly(dl-Lactide-co-Glycolide) Nanoparticles as an Alternative for Sentinel Lymph Node Imaging, Cancer Biotherapy and Radiopharmaceuticals, 25(6): 637-644 (2010)
76. P. Dandekar, R. Dhumal, R. Jain, D. Tiwari , G. Vanage and V. Patravale. Toxicological evaluation of pH-sensitive nanoparticles of curcumin: Acute,sub-acute and genotoxicity studies, Food and Chemical Toxicolog, 48: 2073–2089 (2010)
77. J. Jain, C. Fernandes, V. Patravale. Formulation Development of Parenteral Phospholipid-based Microemulsion of Etoposide, AAPS PharmSciTech, 11(2): 826-31 (2010)
78. V. Patil, P.  Dandekar, V. Patravale, B. Thorat. Freeze Drying: Potential for Powdered Nanoparticulate Product Drying Technology, 28: 624–635 (2010)
79. Y. Bacchav and V. Patravale. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation Acta Pharm, 60: 153–163 (2010)
80. P. Dandekar, R. Jain, S. Patil, R. Dhumal, D. Tiwari, S. Sharma, G. Vanage, V. Patravale. Curcumin Loaded Hydrogel Nanoparticles: Application in Anti-Malarial Therapy and Toxicological Evaluation, J. Pharmaceutical Sci., 9999: 1-19 (2010)
81. R. Jain, S. Nabar, P. Dandekar, P. Hassan, V. Aswal, Y. Talmon, T. Shet, V. Patravale. Formulation and Evaluation of Novel Micellar Nanocarrier for Nasal delivery of Sumatriptan,   Nanomedicine. 5(4): 575-87 (2010)
82. R. Jain, S. Nabar, P. Dandekar, V. Patravale. Micellar Nanocarriers: Potential in Nose to Brain Delivery of Zolmitriptan as Novel Migraine Therapy, Pharm. Res. 27(4): 655-64 (2010)
83. P. Dandekar, R. Jain, C. Kumar, S. Subramanian, G. Samuel, M. Venkatesh, V. Patravale. Curcumin loaded pH‐sensitive nanoparticles for the treatment of colon cancer, J. Biomed. Nanotechnol. 5(5): 1-11 (2009)
84. K. Shah, M. Joshi, V. Patravale. Biocompatible microemulsions for fabrication of glyceryl monostearate solid lipid nanoparticles (SLN) of tretinoin, J. Biomed. Nanotechnol. 5(4): 396-400 (2009)
85. Y. Bacchav, V. Patravale. Microemulsion-based vaginal gel of clotrimazole: formulation, In vitro evaluation, and stability studies, AAPS PharmSciTech  10(2): 476-81 (2009)
86. Y. Bacchav, V. Patravale. SMEDDS of glyburide: formulation, in vitro evaluation, and stability studies, AAPS PharmSciTech. 10(2): 482-487 (2009)
87. P. Dandekar, V. Patravale. Development and validation of a stability-indicating lC method for curcumin, Chromatographia,  69(9‐10): 871-877 (2009)
88. A. Pattani, V. Patravale,  L. Panicker,  P. Potdar. Immunological effects and membrane interactions of chitosan nanoparticles, Molecular Pharmaceutics. 6(2): 345-52 (2009)
89. Y. Bacchav, V. Patravale. Microemulsion based vaginal gel of Fluconazole: Formulation, in vitro and in vivo evaluation, Int. J. Pharm. 365: 175-179 (2009)
90. R. Jain, V. Patravale. Development and Evaluation of Nitrendipine Nanoemulsion for Intranasal Delivery, J. Biomed. Nanotechnol. 5(1): 62-68 (2009)
91. M. Joshi, S. Pathak, S. Sharma, V. Patravale. Design and in vivo pharmacodynamic evaluation of Nanostructured Lipid carriers for parenteral delivery of Artemether: Nanoject, Int. J. Pharm. 364: 119-126 (2008)
92. A. Kale, V. Patravale. Development and evaluation of lorazepam microemulsions for parenteral delivery, AAPS PharmSciTech 9: 966-971 (2008)
93. S. Mandawgade, V. Patravale. Development of SLNs from natural lipids: Application to topical delivery of Tretinoin, Int. J. Pharm.  363: 132–138 (2008)
94. S. Mandawgade, V. Patravale. Development of SMEDDS using natural lipophile: Application to ß-Artemether delivery, Int. J. Pharm.  362: 179–183 (2008)
95. M. Joshi, V. Patravale. Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria, Int. J. Pharm.  362:172–178 (2008)
96. A. Kale, V. Patravale. Design and Evaluation of Self-Emulsifying Drug Delivery Systems (SEDDS) of Nimodipine, AAPS PharmSciTech 9: 191-196 (2008)
97. M. Joshi, V. Patravale. Nanostructured lipid carrier (NLC) based gel of celecoxib, Int. J. Pharm.  346: 124-132 (2008)
98. K. Shah, A. Date, M.  Joshi, V. Patravale. Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery, Int. J. Pharm. 345: 163-171 (2007)
99. Y. Bachhav, A. Date, V. Patravale. Exploring the potential of N-methyl pyrrolidone as a cosurfactant in the microemulsion systems, Int. J. Pharm. 326: 186-189 (2006)
100. A. Pattani, S. Mandawgade, V. Patravale. Development and comparative anti-microbial evaluation of lipid nanoparticles and nanoemulsion of polymyxin B, J. Nanosci. Nanotech. 6: 2986-2990 (2006)
101. M. Joshi, V. Patravale. Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of valdecoxib, Drug Dev. Ind. Pharm. 32: 911-918 (2006)
102. A. Ambarkhane, V. Patravale. Study of solid lipid nanoparticles with respect to particle size distribution and drug loading Pharmazie 58: 392-395 (2003)
103. V. Patravale, V. Nair, S. Gore. High performance thin layer chromatographic determination of nifedipine from bulk drug and from pharmaceuticals Journal Pharmaceutical Biomedical Analysis 23: 623-627 (2000)
104. C. Bhogte, V. Patravale, V. Devarajan. Fluorodensitometric evaluation of gentamicin from plasma and urine by high-performance thin-layer chromatography, Journal of Chromatography B 694: 443-447 (1997)

INDIAN

1. N.  Pandit, V. Patravale. Design and Optimization of a Novel Method for Extraction of Genistein, Ind. J. Pharm. Sci., 73(2): 184-192 (2011)
2. P. Patel and V. Patravale. Commercial Telmisartan Tablets: A Comparative Evaluation with Innovator Brand Micardis, International Journal of Pharma Sciences and Research,1(8): 282-292 (2010)
3. P. Dandekar and V. Patravale. Enzymatic Synthesis of Biosurfactants from Mango Kernel Fat, Indian Journal of Chemical Technology 16: 317-321 (2009) 
4. S. Mandawgade, V. Patravale. Formulation and evaluation of exotic fat based cosmeceuticals for skin repair, Ind. J. Pharm. Sci. 70: 539-542 (2008)
5. R. Jain, S Nabar, V. Patravale. Preparation, Quality Control and Stability of 99mTc-Zolmitriptan Nanocarrier, Ind. J. Nuclear Med. 23: 77-78 (2008) 
6. R. Jain, S Nabar, U Nayak, V. Patravale. Development of radio labeling method for sumatriptan nanocarrier as brain targeted intranasal drug delivery system, Ind. J. Nuclear Med. 22: 112‐113 (2007)
7. V. Patravale, N. Prabhu. Taste Masking of Quinine Sulphate, Ind. J. Pharm. Sci. 67: 233-235 (2005)
8. A. Kale, S. Mandawgade, V. Patravale. Preparation and characterization of polymer based microemulsion system, J. Sur.  Sci.  Technol.  20: 45-52 (2004)
9. V. Patravale, S. Deshpande, K. Krishnan.:Estimation of Mephenesin and Ibuprofen in combination, Indian Drugs 27, 580-581 (1990)
10. V. Patravale, S. Deshpande. Transdermal films of Ibuprofen, Proceed. Innov. Pharm. Sci. and Tech. 74: (1990)  
11. V.  Patravale, S. Deshpande. Transdermal drug delivery system for Ibuprofen, Indian Drugs 26: 107-111 (1988)

INTERNATIONAL

1. P. Kumbhar, K. Kole, V. Khadake, P. Marale, A. Manjappa, S. Nadaf, A. Jadhav, A. Patil, S. Singh, K. Dua, N. Jha, J. Disouza, V. Patravale. Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer. Journal of Controlled Release, 2022, 349, 812-830. 

2. M. Banerjee, K. Nimkar, S. Naik, V. Patravale, Unlocking the potential of drug-drug cocrystals – A comprehensive review, J. Control. Release. 2022, 348, 456-469.

3. V. Chavda, S. Dawre, A. Pandya, L. Vora, D. Modh, V. Shah, D. Dave, V. Patravale. Lyotropic liquid crystals for parenteral drug delivery. Journal of controlled release : official journal of the Controlled Release Society, 2022, 349, 533–549.

4. P. Prasher, M. Sharma , S. Singh, M. Gulati, V. Patravale, B. Oliver, K. Dua. Mucoadhesive particles: an emerging toolkit for advanced respiratory drug delivery. Nanomedicine (London, England). 2022 May;17(12), 821-826.

5. J. Kaur, M. Gulati, N. Jha, J. Disouza, V. Patravale, K. Dua, S. Singh. Recent advances in developing polymeric micelles for treating cancer: Breakthroughs and bottlenecks in their clinical translation. Drug discovery today, 2022, 27(5), 1495–1512.

6. S. Dhoble, V. Patravale, E. Weaver, D. Lamprou, T. Patravale, Comprehensive review on novel targets and emerging therapeutic modalities for pulmonary arterial Hypertension, Int J Pharm.. 2022, 621, 121792.

7. P. Kumbhar, K. Kole, T. Yadav, A. Bhavar, P. Waghmare, R. Bhokare, A.  Manjappa, N. Jha, D. Chellappan, S. Shinde, S. Singh, K. Dua, A. Salawi, J. Disouza, V. Patravale. Drug repurposing: An emerging strategy in alleviating skin cancer. European Journal of Pharmacology, 175031.

8. V P Chavda, A Pandya, E Kypreos, V Patravale, V. Apostolopoulos, Chlamydia trachomatis: quest for an eye-opening vaccine breakthrough. Expert Rev. Vaccines, 2022, 21:6, 771-781.

9. J. Saito, A. Agrawal, V. Patravale, A. Pandya, S. Orubu, M. Zhao, G. Andrews, C. Petit-Turcotte, H. Landry, A. Croker, H. Nakamura, A. Yamatani, S. Salunke. The Current States, Challenges, Ongoing Efforts, and Future Perspectives of Pharmaceutical Excipients in Pediatric Patients in Each Country and Region. Children. 2022; 9(4):453.

10. P. Kakade, A. Chatterjee, A. Pandya, J. Disouza , V. Patravale. Carbohydrate anchored lipid nanoparticles. Int J Pharm. 2022 Apr 25;618:121681.

11. P. Kumbhar, A. Manjappa, R. Shah, N. Jha, S. Singh, K. Dua, J. Disouza, V. Patravale. Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges. J. Control. Release. 2022 Jan 1;341, 1-5.

12. V. Chavda, A. Pandya, S. Pulakkat, M. Soniwala, V. Patravale, Lymphatic filariasis vaccine development: neglected for how long? Expert review of vaccines, 2021, 20(11), 1471–1482.

13. V. Chavda, L. Vora, A. Pandya, V. Patravale. Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management. Drug discovery today, 2021, 26(11), 2619-2636.

14. S. Mhatre, V. Patravale. Drug repurposing of triazoles against mucormycosis using molecular docking: A short communication. Computers in biology and medicine, 2021, 136, 104722.

15. P.S. Kumbhar, A.K. Pandya, A.S. Manjappa, J.I. Disouza, V.B. Patravale, Carbohydrates-based diagnosis, prophylaxis and treatment of infectious diseases: Special emphasis on COVID-19. Carbohydrate Polymer Technologies and Applications, 2, 100052, (2021)

16. Y. Mirchandani, V. Patravale, S. Brijesh. Solid lipid nanoparticles for hydrophilic drugs. Journal of Controlled Release, 335, 457-464, (2021)

17. S. Mhatre, T. Srivastava, S. Naik, V. Patravale. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review. Phytomedicine, 85, 153286 (2021)

18. A. Pandya, V. Patravale, Computational avenues in oral protein and peptide therapeutics. Drug Discovery Today, 26 (6), 1510-1520 (2021)

19. S. Talkar, V. Patravale. Gene Therapy for Prostate Cancer: A Review, Endocrine, Metabolic & Immune Disorders-Drug Targets, 21(3), 385-396 (2021)

20. P. Upadhaya, S. Pulakkat, V. Patravale. Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management. Drug Deliv. and Transl. Res. doi: 10.1007/s13346-020-00747-y (2020)

21. S. Dharadhar, A. Majumdar, S. Dhoble, V. Patravale. Microneedles for transdermal drug delivery: a systematic review, Drug Development and Industrial Pharmacy, doi: 10.1080/03639045.2018.1539497 (2018)  

22. S. Mapara, V. Patravale. Medical capsule robots: A renaissance for diagnostics, drug delivery and surgical treatment, Journal of Controlled Release. doi: 10.1016/j.jconrel.2017.07.005 (2017)

23. R. Pawar, V. Patravale. Dengue Diagnosis: Challenges and Opportunities, Immunochemistry and Immunopathology: Open Access 1:105. doi: 10.4172/icoa.1000105 (2015)

24. R. bhuptani, K. Deshpande, V. Patravale. Transungual permeation: current insights, Drug Delivery and Translational Research. doi: 10.1007/s13346-015-0259-6 Epub ahead of print (2015)

25. P. Desai, H. Shete, R. Adnaik, J. Disouza, V. Patravale. Therapeutic targets and delivery challenges for Alzheimer’s disease, World Journal of Pharmacology, 4(3): 236-264 (2015)

26. S. Vyas, P. Kakade, M. Chogale, J. Disouza, V. Patravale. Multidimensional ophthalmic nanosystems for molecular detection and therapy of eye disorders, Current pharmaceutical Design, 21(23): 1-16 (2015)

27. R. Prabhu*, V. Patravale, M. Joshi, Polymeric nanoparticles for targeted treatment in oncology: current insights, International Journal of Nanomedicine, 10: 1001-1018 (2015) ( * Video abstract link:  https://www.youtube.com/watch?v=VvHQpVJWtvA) 

28. A. Arsiwala*, P. Desai*, V. Patravale. Recent advances in micro/nanoscale biomedical implants, Journal of Controlled Release, 189: 25-45 (2014) (*Equal Authorship).

29. P. Prabhu, V. Patravale. Potential of Nanocarriers in antigen Delivery: The Path to successful Vaccine Delivery, Nanocarriers, 1(1): 10-45 (2014)

30. H. Shete*, S. Vyas*, V. Patravale, J. Disouza. Pulmonary multifunctional nano-oncological modules for lung cancer treatment and prevention. Journal of Biomedical Nanotechnology. 10(9): 1863-1893 (2014) (*Equal authorship).

31. S. Vyas, V. Patravale. Advances in nanomaterials for diagnosis and therapy of leukemia. Recent patents on Nanomedicine, 4(2): 1-6 (2014)

32. H. Shete, R. Prabhu, V. Patravale, Endosomal Escape: A Bottle Neck in Intracellular Delivery, Journal of Nanoscience and Nanotechnology, 15: 460-474 (2014)

33. A. Arsiwala, A. Raval, V. Patravale. Nanocoatings on implantable medical devices. Pharmaceutical Patent Analyst, 2(4): 499-512 (2013)

34. A. Raut, R. Prabhu, V. Patravale. Psoriasis Clinical Implications and Treatment: A Review, Critical Reviews™ in Therapeutic Drug Carrier Systems, 30(3): 183-216 (2013)

35. R. Mehendale, M. Joshi, V. Patravale. Nanomedicines for treatment of viral diseases: Critical Reviews™ in Therapeutic Drug Carrier Systems, 30(1): 1-49 (2013)  

36. S. Mandawgade , S. Patil , V. Patravale. Surface modification techniques for active targeting of polymeric nanoparticles; Int. J.Pharm. Biosci. Technol.; 1(2):64-82 (2013)

37. P. Patel , C. Fernandes , A. Pol , V. Patravale. Oral Amphotericin B: challenges and Avenues,  Int. J. Pharm. Biosci. Technol.; 1(1): 1-9 (2013)

38. P. Prabhu, V. Patravale, M. Joshi. Nanocarriers for Effective Topical Delivery of Anti-Infectives, Current  Nanoscience, 8(4): 491-503 (2012)

39. P. Prabhu, V. Patravale. The Upcoming Field of Theranostic Nanomedicine: An Overview, Journal of Biomedical Nanotechnology, 8(6): 859-882 (2012)

40. A. Pol and V. Patravale. Seabuckthorn: A rich cocktail of antioxidants and bio-actives. Household and Personal Care Today, 4 (2011)

41. S. Shinde, C. Fernandes, V. Patravale. Recent trends in in-vitro nanodiagnostics for detection of pathogens, Journal of Controlled Release, 159(2): 164-180 (2011)

42. P. Desai, A. Date, V. Patravale. Overcoming poor oral bioavailability using nanoparticle formulations - Opportunities and limitations, Drug Discovery Today: Technologies, 9(2): e87-e95 (2011)

43. P. Prabhu, V. Patravale. Novel Targets for Malaria Therapy; Current Drug Targets, 12: 2129-2143 (2011)

44. C. Fernanes, U. Soni and Patravale V. Nano-interventions for Neurodegenerative Disorders, Pharmacological Research 62(2): 166-78 (2010) 

45. A. Pol and V. Patravale. Novel lipid based systems for improved topical delivery of antioxidants, Household and Personal Care Today, 4 (2009)

46. R. Jain, P. Dandekar, V. Patravale. Diagnostic nanocarriers for sentinel lymph node imaging, J. Control Release., 138(2): 90-102 (2009)

47. A. Pattani, S. Phadnis, V. Patravale. Microsponges: a path-breaking cosmetic innovation, Household and Personal Care Today 2: 45-49 (2008)

48. V. Patravale, S. Mandawgade. Novel cosmetic delivery systems: An application update, Int. J. Cosmet. Sci. 30: 19-33 (2008)

49. A. Date, V. Patravale. Microemulsions: Applications in transdermal and dermal delivery, Crit. Rev. Ther.  Drug Carrier System. 24: 547-596 (2007)

50. A. Date, M. Joshi, V. Patravale. Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles, Adv. Drug Del. Rev.  59: 505-521 (2007)

51. S. Mukherjee, A. Date, V. Patravale, H.  Korting, A.  Roeder, G.  Weindl. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety, Clin. Interven. Aging 1: 327-348 (2006)

52. I. Khan, V. Patravale. The intra-vascular stent as a site-specific local drug delivery system, Drug Dev. Ind. Pharm.  31: 59-78 (2005)

53. A. Date, V. Patravale. Current strategies for engineering drug nanoparticles, Cur. Opin. Colloid. Interface Sci.  9: 222-235 (2004)

54. V. Patravale, A.  Date, R.  Kulkarni. Nanosuspensions: A promising drug delivery strategy, J. Pharm. Pharmacol.  56: 827-840 (2004)

INDIAN

1. V. Patravale. COVID-19: New paradigms for disease management. Indian Drugs, 57(3) (2020)

2. C. Bora, R. Prabhu, V. Patravale. Lymphatic delivery: concept, challenges and applications, Indian Drugs. 54(08): 5-22 (2017) (termed as REVIEW OF EXCELLENCE by Indian Drugs)

3. A. Pattani, V. Patravale. Introducing molecular bio-pharmaceutics in the post graduate level curriculum, Ind. J. Pharm. Edu. Res.  42: 46-49 (2008)

4. A. Pattani, M. Degani, V. Patravale. Chitosan: properties, limitations and chemical modifications, Int. J. Pharma. Excip. 6: 47-51 (2007)

1. S. Dhoble, P. Shah, and V. Patravale, Nutribiotics – For good health and beyond. Association of pharmaceutical teachers of India (APTI) newsletter (November Issue) (2020)

2. A. Pandya, V. Patravale, E-learning: Empowering Education Head. Association of pharmaceutical teachers of India (APTI) newsletter (April Issue) (2020)

3. V. Ghodake, P. Shah, and V. Patravale. Use of cannabis: Heralding new era of beauty. Ingredients South Asia (2019)

4. Sreeranjini P, Vandana B. Patravale. 3D bioprinting: The digital healthcare revolution. Pharmabiz (2018)

5.  A. Pandya, V. Patravale. Surgical Glues: A step towards painless clinical practice. Pharmabiz (2018)

6.  P. Shah, V. Patravale. Microsponges’ nature ideal for cosmeceuticals. Ingredients South Asia (ISA) (2018)

7.  R. Pawar, V. Patravale. Theranostic Nanomedicine: An Upcoming Frontier. PharmaTimes (2018)

8.  R. Bhuptani, V. Patravale. Marine derived skin lightners: New paradigm. Ingredients of South Asia-CPHI worldwide (2017)

9.  R. Bhuptani, V. Patravale. Anti-pollution range: New realm in skin care. Ingredients of South Asia-CPHI worldwide (2017)

10.  P. Kakade, V. Patravale. Biomimetic - Nanocomposite Drug Delivery Systems. Chronical Pharmabiz-CPHI (2017)

11.  D. Shah, V. Patravale. Stem Cell Secretomes in Regenerative Medicine. Chronical Pharmabiz-CPHI (2017)

12.  R. Bhuptani, V. Patravale. Stem cell-laden microscaffolds: A new paradigm. Chronical Pharmabiz-CPHI (2016)

13.  R. Prabhu, V. Patravale and S. Aher. Confocal Microscopy: An Important Tool in Pharmaceutical Research, CRS-IC Newsletter, 8: 23-27 (2016)

14. A, Arsiwala, P. Desai., B. Bacchav, V. Patravale. Pharmaceutical cocrystals: are they the next big thing?; Pharmabiz, Chronical Special Issue - CPHI November 28 (2013)

15. P. Desai, A. Lokhande, V Patravale. Aptamers: The Genesis of Nanogenetics for Neuro-Ailments; Pharmabiz, 13(13): 8 (2013)

16. “Supercritical Fluids: Simplifying nanotechnology”; Swami M. and Patravale V. ; CRS-IC newsletter (2012)

17. “Drug-Nutraceutical Interactions: A Revelation”; Pai A. and Patravale V. ; CRS-IC newsletter (2012)

18. M. Swami and V. Patravale. Rapid expansion of supercritical solution, Pharmabiz, July 28 (2010)

19. L. Kate, A. Pol, V. Patravale. Advantages of oral fast dissolving films, Pharmabiz, September 22 (2010)

20. V. Mody, R. Jain, V. Patravale. Intra-vascular stents: Scaffolds   for drug, cell and gene delivery,  Pharmabiz, November 11 (2009)

21. M. Joshi and V. Patravale. Future of nanotechnology in pharma industry, Pharmabiz, November 26 (2009)

22. U. Soni, P. Dandekar and V. Patravale. Solid Lipid Nanoparticles: Scope and Challenges Pharmabiz (2008)

23. P. Dandekar and V. Patravale. Nanomedicine: New Promise, Pharmabiz (2007)

24. R. Jain, P. Dandekar & V. Patravale. Improvising drug delivery - The nano way Pharmabiz (2007)

25. A. Date, A. Kale V. Patravale. Self Microemulsifying Drug Delivery systems, Pharma Technology, Express Pharma Pulse Special Feature, May (2003)

26. V. Patravale, M. Joshi. Solid Lipid Nanoparticles: Potential in Drug Delivery, Souvenir of 5th International symposium on Innovations in Pharmaceutical Sciences and Technology, organized by the B. V. Patel PERD Center, Mumbai, February (2003)

27. V. Patravale. Microemulsions for enhanced transdermal drug delivery, Souvenir, 4th International symposium on Innovations in Pharmaceutical Sciences and Technology, organized by the B. V. Patel PERD Center, Ahmedabad, February (2000)

28. V. Patravale. Hard Capsules with Soft Centers-A Review, Technology Challenges in Drug Industry, Express Pharma Pulse, September (1999)

29. V. Patravale and A. Ambarkhane. Solid Lipid Nanoparticles as Drug Delivery systems, Express Pharma Pulse, November (1999)